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Tumor suppressor genes are classiﬁed by their somatic behavior either as caretakers (CTs) that maintain DNA integrity or
as gatekeepers (GKs) that regulate cell survival, but the germ line role of these disease-related gene subgroups may differ.
To test this hypothesis, we have used genomic data mining to compare the features of human CTs (n 5 38), GKs (n 5
36), DNA repair genes (n 5 165), apoptosis genes (n 5 622), and their orthologs. This analysis reveals that repair genes
are numerically less common than apoptosis genes in the genomes of multicellular organisms (P , 0.01), whereas CT
orthologs are commoner than GK orthologs in unicellular organisms (P , 0.05). Gene targeting data show that CTs are
less essential than GKs for survival of multicellular organisms (P , 0.0005) and that CT knockouts often permit
offspring viability at the cost of male sterility. Patterns of human familial oncogenic mutations conﬁrm that isolated CT
loss is commoner than is isolated GK loss (P , 0.00001). In sexually reproducing species, CTs appear subject to less
efﬁcient purifying selection (i.e., higher Ka/Ks) than GKs (P 5 0.000003); the faster evolution of CTs seems likely to be
mediated by gene methylation and reduced transcription-coupled repair, based on differences in dinucleotide patterns
(P 5 0.001). These data suggest that germ line CT/repair gene function is relatively dispensable for survival, and imply
that milder (e.g., epimutational) male prezygotic repair defects could enhance sperm variation—and hence environmental
adaptation and speciation—while sparing fertility. We submit that CTs and repair genes are general targets for
epigenetically initiated adaptive evolution, and propose a model in which human cancers arise in part as an evolutionarily
programmed side effect of age- and damage-inducible genetic instability affecting both somatic and germ line lineages.
Introduction
A longstanding debate in evolutionary biology con-
cernshowspeciesofincreasingstructuralcomplexitymain-
tain their capacity for genetic variation—and, hence,
adaptation and divergence—despite a predictably increas-
ing need for genetic ﬁdelity (Gulick 1893; Gould JL and
Gould CG 1997). Relevant to this conﬂict, Cope’s rule pos-
tulates that increasing body size creates a short-term repro-
ductive advantage for the individual organism (Kingsolver
and Pfennig 2004) while worsening long-term extinction
risk for the clade (Van Valkenburgh et al. 2004; Hone
and Benton 2005). This trade-off suggests that higher
evolving organisms are subject to a progressive ‘‘Red
Queen’’–type clash between intensifying negative selection
for phenotypic stability and weakening positive selection
forgenotypicvariability(Markov2000)—consistentwith
the modest proportion (0.03%) of coding sequence esti-
mated to have been positively selected in humans, when
compared with that negatively selected (2.5–5%) in
humans or positively selected in simpler species such
as Drosophila (20%) (Ponting and Lunter 2006). Indeed,
prevailing theory teaches that most genetic novelty re-
sults from ﬁxation of random (nonadaptive) drift affect-
ing neutral (Kimura 1968) or near-neutral (Ohta 1998)
alleles, rejecting the Lamarckian doctrine that environ-
mental pressures can drive (i.e., not merely ﬁx) beneﬁcial
mutations.
In previous work, we showed that silent mutations
may nonrandomly affect intragenic sites of differing func-
tional importance (Epstein et al. 2000; Lin et al. 2003) and
that such mutational patterns vary with both strand-speciﬁc
transcription-related DNA repair (Tang et al. 2006) and
gene expression levels (Tang and Epstein 2007). It there-
fore remains plausible that ambient stressors such as heat
(Maresca and Schwartz 2006), starvation (Hastings et al.
2004), inﬂammation (Blanco et al. 2007; Lavon et al.
2007), toxins (Salnikow and Zhitkovich 2008), free radical
injury (Cerda and Weitzman 1997), or other sources of
DNA damage (Ponder et al. 2005) could modify gene tran-
scription and thus alter the rate of mutations affecting ﬁt-
ness (Galhardo et al. 2007)—including the occasional
generation of beneﬁcial mutations (Monk 1995; Elena
and de Visser 2003; Nei 2005). Clues favoring this induc-
ible (adaptive) evolutionary paradigm over neutrality for
metazoan genomes—as is already accepted for bacterial
(Ponder et al. 2005; Cirz and Romesberg 2007) and plant
genomes (Galloway and Etterson 2007)—include faster-
than-expected rates of phenotype acquisition, close tem-
poral correlation with environmental changes, proof of
improved ﬁtness, or convergence (Levasseur et al. 2007).
A mechanism for such non-Darwinian genomic plas-
ticity has been suggested in recent times by the discovery of
heritable epigenetic changes capable of reprogramming de-
velopmental and adult gene expression (Martin et al. 2005;
Morgan et al. 2005), coupled with the predisposition of
such changes to cause germ line mutations (Cooper and
Krawczak 1989) or postzygotic mosaicism (Ohlsson
et al. 1999) that sometimes cause disease (Andrews et al.
1996; Smith and Hurst 1998; Esteller et al. 2001). The fre-
quency of germ line epimutations or imprinting errors—
estimated to be an order of magnitude higher than that of
germ line mutations (Horsthemke 2006)—can be either en-
vironmentally regulated (Dolinoy and Jirtle 2008), as illus-
trated by the inducibility of spermatogonial stem cell DNA
hypermethylation by air pollution (Yauk et al. 2008), or pa-
rentally age dependent (Oakes et al. 2003; Perrin et al.
2007). If such epimutations affect modiﬁer genes involved
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nerational genetic instability (i.e., a mutator phenotype)
may result (Jacinto and Esteller 2007), leading not only
to an increase in deleterious (puriﬁable) mutations (Wu
et al. 2007; Morak et al. 2008) but also to occasional advan-
tageous (positively selectable) mutations (Sniegowski et al.
2000; Cirz and Romesberg 2007) and/or speciation events
(Sniegowski 1998). Selection of such ‘‘driver’’ beneﬁcial
mutations may lead in turn to ‘‘hitchhiking’’ of mutator
(epi)mutations in modiﬁer genes (Johnson 1999)
as ‘‘passengers’’ (Frohling et al. 2007). Such mutational
buffering could enhance evolvability (Wagner 2008)—
consistent with the idea that error-free DNA repair may
be maladaptive in mutagenic or stressful environments
(Breivik and Gaudernack 2004; Ponder et al. 2005;
Siegl-Cachedenier et al. 2007)—yet may also impair per-
formance and hence robustness (Lenski et al. 2006; Frank
2007; Petrie and Roberts 2007). The ‘‘evo-devo’’ conun-
drum thus remains as to whether evolvability is indeed se-
lectable (Hendrikse et al. 2007; Lynch 2007), and if so, by
what mechanism (Colegrave and Collins 2008; Pigliucci
2008). Even if such a mechanism exists (King and Jukes
1969; Monk 1995), traditional thinking predicts that such
selection may act only very weakly at a ‘‘good-for-the-
species’’ level (Hiraiwa-Hasegawa 2000).
We have addressed this dilemma by comparing 2 clas-
ses of human genes implicated in prevention of cancer,
a disease of disordered microevolution (Gatenby and
Vincent 2003; Iwasa et al. 2004; Breivik 2005). Tumori-
genesis is potentiated by genomic instability (Schneider
andKulesz-Martin2004;Bielasetal.2006)arisingviamul-
tistep inactivation of so-called tumor suppressor genes
(Nowak et al. 2004), which, like proto-oncogenes, have
beenreported tobe under strong negative selection pressure
(Thomas et al. 2003). These carcinogenic loss-of-function
events mainly affect DNA repair—mediated by caretaker
genes (CTs) such as BRCA1 and MLH1—or apoptosis, me-
diated by gatekeeper genes (GKs) such as TP53 and Rb
(Kinzler and Vogelstein 1997). These suppressor gene sub-
sets, as well as their disease-causing mutations (Futreal
et al. 2004; University Medical Center Groningen 2006),
are distinguishable using gene databases (Doctor et al.
2003; Woodet al.2005).Althoughlongregardedas recessive
oncogenesthatrequire2‘‘hits’’fordiseaseexpression(Knudson
2000), suppressor genes are increasingly recognized to ex-
hibit clonal haploinsufﬁciency in tumors (Santarosa and
Ashworth 2004; Smilenov 2006). Given recent evidence for
the role of adaptive evolution in cancer progression (Babenko
et al. 2006; Crespi and Summers 2006), the occurrence of
such haploinsufﬁciency supports the view that gene loss
and pseudogenization (‘‘less is more’’) can accelerate ge-
nome evolution in certain contexts (Olson 1999). Because
deleterious mutations (those causing genetic death) are
purged by negative selection, whereas nondeleterious mu-
tations may be positively selected, systematic comparison
of CT and GK evolutionary rates should clarify whether
these repair and apoptosis gene subsets are subject to dis-
tinct evolutionary forces. Consistent with this possibility,
comparisons of human and chimpanzee genomes have
conﬁrmed different evolutionary rates in functionally dis-
tinct gene categories related to tumorigenesis (Clark et al.
2003; Bustamante et al. 2005; Nielsen et al. 2005; Kelley
et al. 2006; Voight et al. 2006), whereas adaptive evolu-
tion of the BRCA1 CT has been well documented (Huttley
et al. 2000; Fleming et al. 2003; Pavlicek et al. 2004).
Here, we use genomic data mining to test the hypothesis
that germ line CTs are commoner targets for methylation-
dependent mutational inactivation than are GKs and,
hence, that repair gene dysfunction contributes both to
germ line evolvability and somatic tumor progression.
A male-dependent prezygotic mechanism for this process,
which we have termed programmed genetic instability or
PGI (Epstein and Zhao 2006a), is also presented.
Materials and Methods
Identiﬁcation and Classiﬁcation of CTs and GKs
We mined data to compare the structural and func-
tional characteristics of human CTs and GKs (see supple-
ment1[SupplementaryMaterialonline]forsources).Given
the multigenic interdependence of DNA repair and cellular
apoptosis (Wee and Aguda 2006), unambiguous identiﬁca-
tion of genes that exclusivelymediate 1of these 2processes
is not straightforward. We sought to minimize the ‘‘noise’’
ofthisfunctionaloverlapin2ways.First,weusedafamilial
tumor suppressor gene database (Futreal et al. 2004; Uni-
versity Medical Center Groningen 2006) to restrict the
choice of genes to those with major neoplastic effects (i.e.,
heritable cancer syndromes) when deleted in the germ line;
this yielded a total of 74 tumor suppressor genes (table 1).
Second, by cross-correlating the former data set with a da-
tabaseofDNA repairgenes(Wood etal.2005),wesubclas-
siﬁed this familial cancer susceptibility gene subset as CTs
(n 5 38) and then designated the remainder—the majority
of which were conﬁrmed to mediate apoptosis (Doctor et al.
2003)—as GKs (n 5 36; table 1).
Analyses of Gene Sequences, Mutations, and
Evolutionary Rate
Human and mouse reference sequences, and species
gene numbers, were downloaded from NCBI Entrez Gene
(http://www.ncbi.nlm.nih.gov/Entrez/Gene). Mutation data
were downloaded from the Human Gene Mutation Data-
base. K-estimator 6.1 (with window size of 33 codons
and step size of 10 codons using Kimura 2-parameter
[2p] method) (Comeron 1999) and PAML 3.15 with
yn00 model (Yang and Nielsen 2002) were used for evo-
lutionary rate calculations. For analysis of gene evolution-
ary proﬁles, we downloaded coding sequences from
Ensembl (http://www.ensembl.org). Kendall package from
R-gui (http://www.r-project.org) was used for statistical
analysis. Other analyses were done using MATLAB
(7.6) Statistical Toolbox (5.1) (http://www.mathworks.
com) for principal component analysis and nonparametric
tests, and R-gui (2.60) for v
2 or Fisher’s exact test.
Supergene Concatenation
Orthologous gene sequences of human, mouse, rat,
chimpanzee, and rhesus monkey were aligned with amino
1738 Zhao and Epsteinacid sequences using ClustalW (Thompson et al. 1994),
then reverted to codon sequences. In-house Perl scripts
(available upon request) were developed for aligned co-
don concatenation. All the aligned CT and GK sequences
were concatenated for supergene construction—23,100
codons for the GK supergene and 32,335 for the CT su-
pergene. The supergene tree was constructed using
a neighbor-joining method, with a modiﬁed Nei–
Gojobori approach, as input in MEGA4 (codon substitu-
tion number Molecular Evolutionary Genetics Analysis
software, version 4.0), producing 2 types of tree: synon-
ymous and nonsynonymous substitution trees.
Coding Sequence Feature Analysis
We used reference sequences downloaded from
NCBI Entrez Gene. For multiple splicing forms, the lon-
gest coding sequence was used for analysis. Mono- and
dinucleotide composition was assessed using in-house
Perl scripts. Additional methodologic details are supplied
in the supplements, text, and legends (Supplementary Ma-
terial online).
Results
Phylogenetic Comparison of CT and GK Orthologs
As an initial assessment, we quantiﬁed the numbers of
human CT and GK orthologs among species of differing
biological complexity. Table 2 shows that orthologs of hu-
man CTs occur more often than those of GKs in unicellular
(P 5 0.047) than in multicellular organisms (P 5
0.192)—suggesting that CTs are phylogenetically older,
whereas GKs may be more essential to the evolution of
multicellular organisms. Although this phylogenetic rise
in GK ortholog frequency may reﬂect selection for in-
creased developmental complexity as predicted by Cope’s
rule, it may also reﬂect the increasing importance of polic-
ing rogue elements (either intragenomic elements like
meiotic drivers or intercellular outlaws like cancer cells)
as multicellularity evolves and organismal cell number
increases.
We next assessed differences in CT and GK gene es-
sentiality (Liao et al. 2006) based on deletion, RNAi, and
gene-targeting data (supplement 2, Supplementary Material
online). This analysis shows that germ line GK ortholog
disruption is more often lethal than CT knockout in
Table 1
Classiﬁcation of CT and GK Suppressor Genes, Listing RefSeq, EntrezGene, and Ensembl Identiﬁers
CTs RefSeq Entrez Gene Ensembl GKs RefSeq Entrez Gene Ensembl
1 ATM NM_000051 472 ENST00000278616 APC NM_000038 324 ENST00000257430
2 BLM NM_000057 641 ENST00000355112 AXIN2 NM_004655 8313 ENST00000307078
3 BRCA1 NM_007295 672 ENST00000309486 BMPR1A NM_004329 657 ENST00000372037
4 BRCA2 NM_000059 675 ENST00000267071 BUB1B NM_001211 701 ENST00000287598
5 BRIP1 NM_032043 83990 ENST00000259008 CDC73 NM_024529 79577 ENST00000367436
6 DDB2 NM_000107 1643 ENST00000256996 CDH1 NM_004360 999 ENST00000268794
7 ERCC2 NM_000400 2068 ENST00000221481 EXT1 NM_000127 2131 ENST00000378204
8 ERCC3 NM_000122 2071 ENST00000285398 MEN1 NM_130803 4221 ENST00000337652
9 ERCC4 NM_005236 2072 ENST00000311895 NF1 NM_000267 4763 ENST00000358273
10 ERCC5 NM_000123 2073 ENST00000375971 NF2 NM_000268 4771 ENST00000338641
11 ERCC6 NM_000124 2074 ENST00000355832 PRKAR1A NM_212472 5573 ENST00000358598
12 ERCC8 NM_000082 1161 ENST00000265038 PTCH NM_000264 5727 ENST00000331920
13 FANCA NM_000135 2175 ENST00000305699 PTEN NM_000314 5728 ENST00000371953
14 FANCB NM_001018113 2187 ENST00000340604 RB1 NM_000321 5925 ENST00000267163
15 FANCC NM_000136 2176 ENST00000289081 SBDS NM_016038 51119 ENST00000246868
16 FANCD2 NM_033084 2177 ENST00000287647 SDHB NM_003000 6390 ENST00000375499
17 FANCE NM_021922 2178 ENST00000229769 SDHC NM_003001 6391 ENST00000367975
18 FANCF NM_022725 2188 ENST00000327470 SDHD NM_003002 6392 ENST00000375549
19 FANCG NM_004629 2189 ENST00000378643 SMAD4 NM_005359 4089 ENST00000342988
20 FANCL NM_018062 55120 ENST00000233741 SMARCB1 NM_001007468 6598 ENST00000344921
21 FANCM NM_020937 57697 ENST00000267430 STK11 NM_000455 6794 ENST00000326873
22 LIG4 NM_002312 3981 ENST00000310534 SUFU NM_016169 51684 ENST00000369902
23 MLH1 NM_000249 4292 ENST00000231790 TCF1 NM_000545 6927 ENST00000257555
24 MLH3 NM_014381 27030 ENST00000238662 TSC1 NM_000368 7248 ENST00000298552
25 MRE11A NM_005591 4361 ENST00000323929 TSC2 NM_000548 7249 ENST00000219476
26 MSH2 NM_000251 4436 ENST00000233146 TSHR NM_000369 7253 ENST00000298171
27 MSH3 NM_002439 4437 ENST00000265081 VHL NM_000551 7428 ENST00000256474
28 MSH6 NM_000179 2956 ENST00000234420 WT1 NM_024426 7490 ENST00000379079
29 MUTYH NM_012222 4595 ENST00000372112 CDK4 NM_000075 1019 ENST00000257904
30 NBN NM_001024688 4683 ENST00000265433 CHEK2 NM_001005735 11200 ENST00000382580
31 PMS1 NM_000534 5378 ENST00000342075 CYLD NM_015247 1540 ENST00000311559
32 PMS2 NM_000535 5395 ENST00000265849 EXT2 NM_000401 2132 ENST00000358681
33 POLH NM_006502 5429 ENST00000372236 FH NM_000143 2271 ENST00000205832
34 RAD51 NM_002875 5888 ENST00000382643 FLCN NM_144997 201163 ENST00000285071
35 RECQL4 NM_002907 5965 ENST00000314748 GPC3 NM_004484 2719 ENST00000370818
36 WRN NM_000553 7486 ENST00000298139 TP53 NM_000546 7157 ENST00000269305
37 XPA NM_000380 7507 ENST00000259463
38 XPC NM_004628 7508 ENST00000285021
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0.00001, Fisher’s exact test, 2 sided) but not in unicellular
organisms (yeast deletions; P 5 0.63; table 2). Hence, rel-
ative to GK function, germ line CT function appears selec-
tively dispensable in multicellular organisms.
Analysis of mammalian gene-targeting phenotypes
further reveals that, unlike GK knockouts, viable CT
knockouts are associated with male sterility (table 2).
We infer from this ﬁnding that CT dysfunction selectively
permits (organism) viability at the expense of (genetic) ﬁ-
delity, severe defects of which might be expected to cause
sperm dysfunction or death. As discussed below, however,
the possibility is raised that less profound (i.e., nondeletion-
al or epimutational) germ line repair deﬁciencies could be
associated with offspring fertility.
To assess further the impact of repair and apoptotic
gene defects transmitted through the germ line, we com-
pared CT and GK mutation frequencies in cancer families
and somatic tumors. This shows that isolated germ line CT
mutations are commoner than isolated GK mutations (P ,
0.00001; table 3), reinforcing the notion that CT/repair
function is signiﬁcantly more dispensable for survival than
is GK/apoptosis function.
Phylogenetic Analysis of Apoptosis versus Repair
The foregoing data apply only to tumor suppressor
genes. To determine whether these results can be general-
ized, we performed a cross-species quantitation of ortho-
logs implicated in either apoptosis or repair (supplement
1, Supplementary Material online). Based on the assump-
tions that organism complexity is increasing from yeast to
humans and that assignation of gene ontology includes
some random effects, we performed Kendall rank test
(R-gui Kendall package, www.r-project.org) for correlation
analysis of DNA repair genes and apoptosis genes. As
shown in ﬁgure 1A, phylogenetic differences in apoptosis
gene numbers are signiﬁcant (tau 5 1, 2-sided P 5
0.008535), whereas for DNA repair genes this is not the
Table 2
Phylogenetic and Gene Essentiality Proﬁles of Familial
Cancer Syndrome Genes
Parameters CTs GKs P value
Yeast orthologs 0.047
Present 30 20
Absent 8 16
Worm orthologs 0.192
Present 30 33
Absent 8 3
Yeast essentiality 0.63
Deletion lethal 3 2
Deletion nonlethal 27 18
Worm essentiality 0.003
RNAi lethal 1 11
RNA nonlethal 29 22
Mouse essentiality ,0.00001
Knockout lethal 4 28
Normal 21 8
Male infertility 13 0
NOTE.—.For yeast phylogenetic analysis, CT analysis excludes the numerous
Fanconi anemia gene orthologs in order to avoid data confounding. Gene knockout
phenotypes were sourced using data mined from http://www.informatics.jax.org/.
All P values were computed using Fisher’s exact test (2 sided).
Table 3
Mutational Analysis of Familial (germ line) and Sporadic
(somatic) Human Tumor Mutations of CTs and GKs (i.e.,
relative frequencies of familial vs. sporadic human tumor
mutations in the germ line and/or somatic lineages)
Germ line versus
somatic human tumor
mutations
Germ line and
somatic
Germ line
only P value
CT (n 5 38) 6 32 ,0.00001
GK (n 5 36) 25 11
NOTE.—Mutation frequencies were determined by mining Cancer Gene Census
and PubMed with P values computed using Fisher’s exact test (2 sided).
FIG. 1.—Evolutionary characteristics of human CTs and GKs. (A)
Overall quantitation of apoptotic gene versus repair gene number in
different phyla: human (H. sapiens), mouse (Mus musculus), ﬁsh (D.
rerio), ﬂy (D. melanogaster), worm (C. elegans), and yeast (S. pombe).
Blue ﬁlled squares, DNA repair genes; red ﬁlled circles, apoptosis genes;
black stars, total gene number of respective genome from Ensemble 49
(www.ensembl.org). Data were mined as detailed in the Materials and
Methods. (B) Relative divergence of CT and GK genes in mammals
(human–mouse; divergence time approximately 85 MYA) and worms
(C. elegans–C. briggsae; divergence time approximately 100 MYA)
quantiﬁed using Ka/Ks. Blue squares, CT orthologs; red circles, GK
orthologs. (C) Principal component analysis with parameters of Ka/Ks of
CTs and GKs. We normalized the computed 10 pairwise divergence of
human, chimpanzee, rhesus, monkey, mice, and rats using Ka/Ks
analysis. 1st PC, ﬁrst principal component (x axis); 3rd PC, third
principal component (y axis).
1740 Zhao and Epsteincase (tau 5 0.333, 2-sided P 5 0.45237). Considered to-
gether with table 2, this difference conﬁrms that increases
in biological complexity depend more upon apoptotic than
repair gene number.
Comparison of CT and GK Evolutionary Rates
We then used nonparametric 2-sample Kolmogorov–
Smirnov goodness of ﬁt hypothesis testing with kstest2
function (MATLAB, http://www.mathworks.com, statisti-
cal toolbox) for Ka/Ks—a positive correlate of positive se-
lection—ortholog analysis. This conﬁrmed that CTs evolve
more rapidly than GKs in sexually reproducing (human vs.
mouse, estimated divergence time 85 Myr; P 5 0.000003)
but not in self-fertilizing (2 worm species, estimated diver-
gence time 100 Myr; P 5 0.2582) multicellular organisms
(ﬁg. 1B; Kruskal–Wallis test, P , 0.004); Ks was different
in worms (P 5 0.007) but not in mammals (P 5 0.091).
Consistent with ourearlier ﬁnding ofselective male sterility
in CT knockouts, these data support the hypothesis that
rapid CT evolution is related in some way to sexual repro-
duction. Principal component analysis based on evolution-
ary rate as well as variables such as GC content (see ﬁg. 5)
andgenelength(seesupplement3,SupplementaryMaterial
online) provides further visual evidence that CTs and GKs
are distinguishable based on genetic evolutionary parame-
ters (ﬁg. 1C).
We then used neighbor-joining supergene (gene con-
catenation) trees (Zhang et al. 1998) to characterize CT and
GK branchesunderselection. Thismethodology, whichhas
been reported to yield more accurate phylogenetic data than
multigene approaches (Gadagkar et al. 2005), conﬁrms that
accelerated evolution of CTs compared with GKs is evident
in human–macaca, human–mouse, and mouse–rat compar-
isons, though apparently not in human–chimpanzee com-
parisons (ﬁg. 2A). This difference is further illustrated by
a tree diagram showing the distinct divergence parameters
of CTs and GKs (ﬁg. 2B). It is noted that the ratio of mis-
sense to silent mutations (A/S) encoded by CT single-
nucleotide polymorphisms (SNPs) is no higher than in
GKs (supplement 1, Supplementary Material online) and
that, compared with historical data (Zhang et al. 1998;
Fay et al. 2001), larger polymorphisms are present in both
rareandcommonSNPs(P,0.001,Pearson’sv
2).Wehave
also noted that CTs evolve more rapidly than tissue-speciﬁc
genes,whereasGKsevolvemoreslowlythanhousekeeping
genes (P , 0.001, Mann–Whitney U test; data not shown),
emphasizing the wide class differences in evolutionary
rates.
Toexplore possible differences of divergence between
CTs and GKs, we used a sliding window analysis of con-
catenated CT (38 genes, 41,169 codons) and GK (36 genes,
25,968 codons) supergenes. A window size of 33 codons
and step size of 10 codons was used in conjunction with
K-estimator (calculation of the number of nucleotide sub-
stitutions per site and the conﬁdence intervals) 6.1, Kimura
2p model. As shown in ﬁgure 3A, the Ka/Ks (red), but nei-
ther Ka nor Ks (green and blue, respectively), is overrep-
resented in CTs compared with GKs. We further tested the
distribution of these 3 parameters by using the nonparamet-
ric 2-sample Kolmogorov–Smirnov test. Figure 3B con-
ﬁrms that only Ka/Ks is signiﬁcant (P 5 0.0000079) but
neither Ka nor Ks, which correlate with deleterious muta-
tion and neutral mutation rate, respectively (for further de-
tails, see supplement [Supplementary Material online] and
ﬁg. 3).
To check whether human–chimpanzee divergences of
CTs and GKs are in fact similar, as suggested by the ﬁnd-
ings in ﬁgure 2, we used the McDonald and Kreitman
(1991) test for evolutionary rate analysis. Data were mined
as described (Bustamante et al. 2005) using a Poisson ran-
dom ﬁeld model—a variant of the McDonald–Kreitman
test—for divergence versus diversity comparison. Data
were obtained from Celera Genomics, which applied
exon-speciﬁc polymerase chain reaction ampliﬁcation to
20,362 loci in 39 humans and 1 male chimpanzee. We note,
however, that the following genes were not found in this
data set: 9 CTs (BRCA2, BRIP1, FANCD2, FANCM,
MLH1, MLH3, NBN, PMS2, and RECQL4) and 10 GKs
(CDC73, EXT1, NF1, PTCH, SBDS, SDHD, TSHR,
WT1, CHEK2,a n dFH). The following parameters were
FIG. 2.—Evolutionary rate comparison of CTs and GKs. (A)
Distribution of Ka/Ks in pairwise comparisons between CTs and GKs
within 4 lineages including human–chimpanzee (top left), human–macaca
(top right), human–mouse (bottom left), and human–rat (bottom right).
Bin size 0.05 was used for distribution computation. For this
analysis—which compares the different evolutionary rates of human
CTs and GKs using a variety of species comparators, as distinct from
comparing gene evolutionary rates in multiple species—P values were
calculated by ranked 2-sample Mann–Whitney U test using MATLAB
Statistical toolbox function rank sum. (B) Lineage-speciﬁc comparison of
evolutionary rate of CTs and GKs using supergene concatenation. Blue
bars, CTs; red bars, GKs.
Gene evolution and PGI 1741used: synonymous divergence, synonymous polymor-
phism, nonsynonymous divergence (DN), nonsynonymous
polymorphism (PN), and c (Poisson random ﬁeld model
parameters). All mined data are supplied (supplement [Sup-
plementary Material online] and ﬁg. 4). In contrast to ﬁgure
2, these results—which show a higher frequency of GKs
lacking both PN and DN sites relative to CTs (Pearson’s
v
2, P 5 0.0044)—conﬁrm that the rapid evolution of
CTs relative to GKs persisted during the human–chimpan-
zee divergence approximately10 MYA(ﬁg.4A–D).Hence,
havingshownthatCTsevolvedfasterthanGKsbothduring
primate–rodent (ﬁgs. 1–3) and human–chimpanzee diver-
gence (ﬁg. 4), we conclude that the rapid evolution of
CTs is likely independent of timescale.
Sequence-Based Evidence for Evolutionary CT Gene
Methylation
Our previous studies implicated nonrandom CG /
TA transitional mutations (CpG decay) as a correlate of
adaptive evolution in less transcribed (Tang and Epstein
2007) and/or less essential coding sequences (Epstein
et al. 2000); conversely, we have implicated CpG conser-
vation as a correlate of negative selection in more tran-
scribed (Tang et al. 2006) and/or more essential
sequences (Lin et al. 2003). These results suggested an evo-
lutionary paradigm in which concomitant promoter and
coding sequence methylation accelerate (epi)mutational
functional loss of nonessential coding sequences. To test
whether any such methylation-dependent signatures distin-
guish CTs and GKs, we computed the sequence component
of the relevant transcribed coding strand and applied a non-
parametric 2-sample Kolmogorov–Smirnov goodness of ﬁt
hypothesis test with kstest2 function of MATLAB (http://
www.mathworks.com) statistical tool box for all parame-
ters compared. Meaningful CT and GK gene expression
data were unable to be derived from GNF Expression Atlas
FIG. 3.—Sliding window analysis of human–mouse CT and GK
divergence. (A) Evolutionary rates of CTs (top) and GKs (bottom) using
human–mouse alignments (window size 33 codons, step size 10 codons).
Red line, Ka/Ks; blue line, Ks; green line, Ka. Most regions with Ka/Ks
.1.5, with P value ,0.05 (bootstrap threshold computed with K-
estimator 6.1). (B) Distribution of Ka, Ks, Ka/Ks in CTs and GKs using
bin size 0.05 and nonparametric Kolmogorov–Smirnov test, revealing
a signiﬁcant difference of Ka/Ks (P 5 0.0000079), thus conﬁrming more
rapid evolution of CTs than GKs.
FIG. 4.—McDonald–Kreitman testing of CT evolutionary rate
relative to GKs during human–chimpanzee divergence. (A) Distributions
of synonymous divergence (DS), synonymous polymorphism (PS),
nonsynonymous divergence (DN), and nonsynonymous polymorphism
(PN) of CTs and GKs using bin size 1 and nonparametric tests (median of
2 unpaired samples, using the MATLAB 7.6 statistical toolbox rank-sum
function). This shows that DN is the most signiﬁcant parameter (P 5
0.00016), followed by PN (P 5 0.004), with DS and PS not signiﬁcant,
thus conﬁrming rapid CT evolution. (B) R-gui function v
2 test function in
terms of the summarized codon changes of CTs and GKs. This also shows
that the evolutionary rates of CTs and GKs are different (P 5 0.0000037).
(C) Poisson random ﬁeld parametric test. The selection parameters are
illustrated using a 95% conﬁdence interval and show no signiﬁcant
difference (P 5 0.1913, by nonparametric test of equal distribution of 2
samples using function kstest2), presumably reﬂecting numerous non-
change genes in terms of the parameters. (D) Parametric retesting of CT
and GKs in terms of DS, PS, DN, and PN, conﬁrming that CTs evolved
more rapidly than GKs during human–chimpanzee divergence.
1742 Zhao and Epstein2 based on U133A and GNF1H Chips, perhaps reﬂecting
parametric uncertainty (Su et al. 2004). However, for gene
expression-related sequence features relating to CpG muta-
tion and asymmetric transcription-related repair (Tang et al.
2006),wecomparedGCcontent((GþC)/(GþCþAþT),
P 5 0.0106), TA skew ((T   A)/(T þ A), P 5 0.5242), GC
skew((G C)/(GþC),P50.0028),andBfactor((GþT 
A   C)/(A þ T þ G þ C), P 5 0.0860) (Majewski 2003)
(ﬁg. 5A). These differences suggest greater methylation-
dependent mutation of CTs relative to GKs during recent
humanevolution.Wethencomparedthemethylation-related
sequence features of CT/GK transcribed strands, revealing
differences in CpG content (CpG count/total dinucleotide
count, P 5 0.0011), CpA content (CpA count/total dinucle-
otide count, P 5 0.2555), TpG content (TpG count/total
dinucleotide count, P 5 0.0174), and DNA methylation-
related dinucleotide asymmetry (TpG   CpA)/(CpG  
CpG),P50.00105)(ﬁg.5B).Theseresultsindicatelesstran-
scription-related repair of methylated CTs relative to GKs
in germ line–coding sequences. Considered together with
the gene essentiality differences presented in table 2, the
rapid evolution of CTs relative to GKs suggests an epimuta-
tional mechanism for CT functional inhibition that escapes
puriﬁcation while accelerating mutation.
Discussion
The central ﬁnding of this study is that CTs are evolv-
ing more rapidly than GKs and that this process—which
appears likely to be mediated by methylation-dependent
mutation—is conﬁned to higher sexually reproducing spe-
cies. These CT–GK distinctions are consistent with earlier
work showing that apoptosis-regulatory genes are essential
for development of higher organisms (Aravind et al. 2001),
whereas germ line mutation of DNA repair genes drives
species evolution (Fay et al. 2001). However, because loss
of DNA repair capacity also contributes to cancer develop-
ment(Cleaveretal.1995;BreivikandGaudernack 2004),it
is also reasonable to expect tumor suppressor genes in gen-
eral to be under strong purifying selection (Thomas et al.
2003). Here, we propose that this apparent discrepancy
arises from a complex mix of dualistic variables: 1) the bi-
functional evolutionary role of repair genes in either con-
serving genetic information or permitting genetic variation,
depending on selection pressure; 2) the bifunctional ability
of sexual reproduction either to promote (prezygotically)
variation through repair inhibition and intra- or intermale
sperm competition or to conserve (postzygotically) genetic
ﬁdelity through repair activation, apoptosis, and miscar-
riage; and 3) the bifunctional role of CpG dinucleotides
and promoter CpG islands in either enhancing transcription
and repair (when demethylated) or in repressing transcrip-
tion and predisposing to mutation (when methylated).
FIG. 5.—Box plot illustration of CT- and GK-coding sequence
features relating to DNA methylation and gene expression. The boxes
feature lines at the lower quartile, median, and upper quartile values. The
whiskers are lines extending from each end of the boxes to show the
extent of the data; outliers are values beyond the ends of the whiskers.
(A) Comparison of GC content and dinucleotide skew in CTs and GKs.
(B) Frequency of methylation-related dinucleotides and asymmetry in
CTs versus GKs. Outliers are denoted by plus signs.
FIG. 6.—Modelof changing human male CT and GK functionfrom germ
line to somatic contexts. The x axis is divided into the following time
frames: T1, prezygotic spermatogonia and spermatocytes; T2, postzygotic
embryonic development; T3, prereproductive infancy and childhood; T4,
reproductive adult life; and T5, postreproductive senescence. The y axis
models the relative extent of either GK functionality (PCD) or CT
dysfunctionality (PGI) during these time frames. Damage/stress-inducible
prezygotic promoter (CpG island) methylation of spermatogonial/
spermatocyte CTs and GKs, respectively, increases PGI while reducing
PCD—thus maximizing genetic variability in response to changing
environmental selection pressures. Postfertilization male germ line gene
demethylation has the opposite effect, causing a sustained decline in PGI
and a rise in PCD. During postreproductive adult life, an age-dependent
(as well as damage-inducible) methylation clock induces somatic CT/GK
gene inactivation, leading in turn to a senescent rise in PGI and decline of
PCD that predisposes to sporadic tumor outgrowth.
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embryo, where somatic patterns of gene expression are set,
but also during germ cell development (Morgan et al.
2005)—which changes can be heritable for at least 2 gen-
erations (Anway et al. 2008). The methylation dynamics of
sperm/testis DNA are unique (Oakes et al. 2007a); unlike
oocyte DNA, prezygotic protamine-compacted male germ
cell DNA tends to be methylated in nonpromoter regions
(Oakes et al. 2007b) that undergo rapid demethylation fol-
lowing fertilization (Haaf 2006). Such sex-speciﬁc DNA
methylation appears necessary but not sufﬁcient (El-Maarri
et al. 1998) to explain the higher mutation rate of mamma-
lian male germ cells (Agulnik et al. 1997; Hurst and
Ellegren 1998; Wyckoff et al. 2000; Makova and Li
2002)—suggesting in turn that exposures of the (external)
testes to heat (Nikolopoulos et al. 2007), DNA damage
(Barber et al. 2006), or other insults (Hara et al. 1999) could
well play an evolutionarily programmed epimutagenic role,
consistent with the postnatal timing of male germ cell pro-
moter methylation (Driscoll and Migeon 1990). Notably,
this hypothesis differs from the standard view of male-
driven evolution reﬂecting a simple excess of male germ
cell divisions, giving rise in turn to more replicative muta-
tions (Drost and Lee 1995).
In earlier work, we showed that rarely transcribed
genes with promoter CpG islands are hot spots for adaptive
evolution (Tang and Epstein 2007), raising the possibility
that promoter methylation of sperm target gene classes such
as CTs could be a mechanistic ‘‘missing link’’ between en-
vironmental selection for speciﬁc transcriptomes (Su et al.
2004) and/or coding sequence CpG mutations that permit
transgenerational propagation of genetic instability (Wu et al.
2007; Morak et al. 2008). Consistent with this, CTs more
often contain promoter CpG islands than do GKs (Zhao Y,
unpublished data): classic GKs such as TP53 do not contain
promoter CpG islands, whereas canonical CTs such as
MLH1 and BRCA1 do. Instructively, the latter gene is mu-
tated and not methylated in familial cancer syndromes
(Chen et al. 2006), yet is methylated and not mutated in
chemotherapy-induced second malignancies (Scardocci
et al. 2006); similar exclusivity between repair gene meth-
ylation events and oncogenic indels or point mutations in
repair-deﬁcient tumors (Esteller et al. 2001; Toyooka et al.
2006) suggests the ﬂuidity of such epimutations. Although
in this model extrinsic damage is the major regulator of pre-
zygotic male germ cell CT methylation—as well as being
both a cause and effect of progressive suppressor gene re-
pression in precancerous adult somatic tissues (Neri et al.
2007)—age may be as important as damage in the latter
process (Kim et al. 2005), with parental (especially pater-
nal) ageplayingasynergisticroleintheformer (Oakesetal.
2003).
We deﬁne this model of a ‘‘methylation clock’’ regu-
lating the epigenetic inactivation of CT/repair genes in the
male germ line and adult somatic tissues—commensurate
with extrinsic damage/stress or intrinsic ageing/senescen-
ce—as PGI; just as programmed cell death (PCD) is the
mechanism of negative selection, so is PGI proposed to
be the mechanism of positive selection (ﬁg. 6). We suggest
that PGI intensiﬁes genetic divergence during sexual repro-
duction at the level of sperm–egg fusion, in contrast to PCD
which eliminates both oocyte (Suh et al. 2006) and sperm
DNA defects after syngamy (Fatehi et al. 2006). This se-
quence (sperm / ovum, zygote / embryo) of positive
followed by negative selection ﬁts with the notion of sexual
conﬂict (Partridge and Hurst 1998), which should enhance
biological system robustness and evolvability (Kitano
2004). We also note that heritable, though not necessarily
familial, predisposition to carcinogenesis could also be
propagated transgenerationally by PGI (Epstein and Zhao
2006b).
What evidence do we have for PGI operating through
the male germ line? The original hypothesis arose from
prior knowledge, namely, 1) evidence for male-driven evo-
lution from other groups (Agulnik et al. 1997; Hurst and
Ellegren 1998; Wyckoff et al. 2000; Makova and Li
2002); 2) evidence for repair genes being speciation genes,
implying a permissive role in rapid evolution (Radman and
Wagner 1993; Cleaver et al. 1995; Sniegowski 1998); and
3) the external anatomic location of the testis, making male
germcellsuniquelyvulnerabletomutagenic,yetpotentially
reparable, environmental damage (Roest et al. 1996; Hsia
et al. 2003; Feitsma et al. 2007). Against this background,
we needed to integrate the following new data: 1) CT/repair
genes are evolving with unexpected rapidity; 2) CT knock-
outs arerelativelydispensable for survival, resultingonly in
reduced male fertility; and 3) abnormally low CT/repair
gene expression is characteristic of teratozoospermia (Zhao
Y, unpublished data), a condition of abnormal sperm mor-
phology that does not signiﬁcantly reduce in vitro fertiliza-
tion success rates (Keegan et al. 2007). These considerations
invited the hypothesis: could the rapid evolution of CT/
repair genes reﬂect selection for a permissive (i.e., causal
loss-of-function) role in male-driven evolution? This latter
possibility is supported by the ﬁnding that heterozygous
males and homozygous females can remain fertile when
homozygous male repair gene knockouts are sterile (Roest
1996) and that even minimal repair transgene expression
sufﬁces to rescue fertility in repair-knockout males (Hsia
2003). Moreover, homozygous repair-deﬁcient males may
survive—albeit at the cost of tumor susceptibility—in ge-
neticbackgrounds wherehomozygousfemales die (Cranston
et al. 1997). This striking gender-speciﬁc difference strongly
suggestsa male-speciﬁcsigniﬁcance for acceleratedCT evo-
lution, which involves interaction of ambient damage with
selectionforsubtle(e.g.,epimutational)malegermcellrepair
defects.
Our gene targeting and familial cancer data conﬁrm
that germ line CT defects are less lethal than GK defects
(tables 2 and 3). The effects of repair gene targeting depend
critically on the extent of functional inhibition and the pres-
ence or otherwise of associated mutations; in general, mild
(e.g., haploinsufﬁcient) CT/repair defects tend to increase
mutation while decreasing apoptosis (Frank et al. 2005;
Smilenov et al. 2005) and may even enhance ﬁtness and
lifespan (Siegl-Cachedenier et al. 2007), whereas severe re-
pair defects tend to cause increased apoptosis and prema-
ture lethality (Henrie et al. 2003). Hence, because low-level
sperm DNA damage can be repaired after fertilization of
repair-proﬁcient oocytes (Menezo 2006; Marchetti et al.
2007; Fernandez-Gonzalez et al. 2008)—particularly in
the setting of prior DNA damage ‘‘conditioning’’ of such
1744 Zhao and Epsteinoocytes (Agrawal and Wang 2008)—mild nondeletional
prezygotic male germ line repair defects could plausiblyen-
hancespermdivergencewithminimalfertilitycompromise,
thereby safeguarding species’ evolvability while offsetting
transgenerational risks of paternally transmitted birth de-
fects (Marchetti and Wyrobek 2008) or cancer (Zenzes
et al. 1999; Yauk et al. 2007). This conclusion is further
supported by the ﬁnding that chronic exposure of spermato-
gonia to low-dose damage greatly reduces genetic damage
induced by an acute second hit (Cai et al. 1993; Koana et al.
2007). Our ﬁndings therefore suggest the evolution of an
environmentally interactive genetic program for promoting
divergence in the germ line. We note that the related
age-dependent predisposition to cancer is not wholly disad-
vantageous to the species as such mortality may promote
redistribution of environmental resources to younger and
more fertile individuals.
As an extension of the ‘‘immortal strand’’ hypothesis
of stem cell ﬁdelity (Cairns 2006), our ﬁndings raise the
notion that the transcribed (well repaired, CpG-demethy-
lated) DNA strand represents the ‘‘immovable object’’ of
negative selection, whereas the untranscribed (poorly re-
paired, CpG-methylated) strand provides the ‘‘irresistible
force’’ of positive selection. Furthermore, consistent with
the notion that sexual conﬂict selects for distinct gender
phenotypes (Hosken et al. 2001), the evolutionary para-
digm presented here implies that the usual targets of pos-
itive selection—choice and specialization (Barkman 2003;
Hamm et al. 2007), discrimination and success (Swanson
et al. 2003), and beauty (Morris RD and Morris JA
2004)—are intrinsically male (sperm/PGI dependent) in or-
igin, whereas the targets of negative selection (normality,
utility, longevity, and ﬁdelity) are genetically female or oo-
cyte/PCD dependent. Both positively and negatively se-
lected traits are vital for ﬁtness in sexually reproducing
species:forexample,thereproductivesuccessofbutterﬂies,
birds, and peacocks depends on highly variegated yet sym-
metric surface patterns (Gould JL and Gould CG 1997) that
predict a low underlying frequency of deleterious func-
tional mutations (Morris RD and Morris JA 2004). In
our model, PGI is driven by sexual selection pressure on
the male germ line to optimize as opposed to normalize
whatever phenotypes can be optimized—such as sperm ve-
locity (Gage et al. 2004) or ion channel function regulating
motility (Podlaha et al. 2005)—while also enhancing var-
iation in species-discriminatory phenotypes such as egg-
binding proteins (Moller and Cuervo 2003). Hence, the
basis for sexual conﬂict in our model is that ‘‘average’’
can never be ‘‘best’’ and that ‘‘health’’ may not guarantee
‘‘popularity’’ (Zaidel et al. 2005)—whether with respect to
beauty (DeBruine et al. 2007) or to sperm competition (Neff
and Pitcher 2005)—thus helping to explain the paradox that
mutation rates tend to be reduced by natural selection yet in-
creased by sexual selection (Moller and Cuervo 2003).
In conclusion, we have shown that CTs are less essen-
tial for germ line viability and hence more rapidly evolving
than GKs. The resulting model of PGI implicates sexual
reproduction as an evolutionary masterstroke: uniquely,
sex plays off prezygotic positive selection (in which epimu-
tational divergence is accelerated by environmental stress
and damage, and efﬁciently selected and ﬁxed by intra-
and/or intermale sperm competition) against the evolution-
arysafetyvalvesofpostzygoticrepairandnegativeselection
(Menezo 2006). Via this mechanism, we propose that envi-
ronmental stressors succeed in the otherwise oxymoronic
task of ‘‘selecting for divergence’’ via epigenetic inhibition
of DNA repair, thus helping to settle the ‘‘4-billion-year
struggleofselﬁshgenestobalancetheneedforvariationwith
theequallyimportantgoalofconservingsuccess’’(GouldJL
andGouldCG1997).Moreover,iftumorsdoindeedarisein
partasasideeffectofPGI,cancersusceptibilitymaybemost
accurately viewed as the tumor-permissive ‘‘price’’ paid by
multicellular organisms for genetic plasticity, with the spe-
ciesreapingtheultimateevolutionary‘‘reward’’ofadelayed
time to extinction.
Supplementary Material
Supplement 1, 2, and 3 are available at Molecular
Biology and Evolution online (http://www.mbe.
oxfordjournals.org/).
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